Skip to main content
Log in

Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Administration of drugs by the sublingual route provides rapid systemic absorption and avoids first-pass metabolism. The purpose of the present study was to assess the pharmacokinetics, efficacy and adverse effects of standard salbutamol tablets given by this route to patients with asthma. Seven asthmatic patients were given either sublingual salbutamol tablet 2 mg (SL), swallowed tablet 2 mg (O), metered dose inhaler 200 µg (MDI) or placebo (PL), in a randomized single-blind cross-over design. Airways responses (FEV1, FVC, PEFR), finger tremor (Tr), heart rate (HR), plasma potassium (K) and plasma salbutamol were measured over a 6 h period following drug administration.

There were highly significant changes in FEV1 with MDI, O and SL routes compared with PL, although the response to MDI was greater and more rapid than with O or SL. There were similar findings for FVC and PEFR responses. There were no adverse effects with MDI, whereas both 0 and SL produced significant tremor responses. There were no differences between O and SL for any of the pharmacodynamic parameters. In addition, pharmacokinetic profiles for O and SL were also similar apart from an initial delay in absorption with SL. There were however, no significant differences in any of the pharmacokinetic parameters, between O and SL.

This suggests that buccal absorption of salbutamol was negligible, and that systemic absorption occurred after swallowing of the dissolved sublingual tablet. These results show that sublingual administration of salbutamol tablet has no clinical benefit over the oral route.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Walker SR, Evans ME, Richards AJ, Paterson JW (1972) The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 13: 861–867

    Google Scholar 

  2. Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP (1986) Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 22: 587–593

    Google Scholar 

  3. Goldstein DA, Tan YK, Soldin SJ (1987) Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol 32: 631–634

    Google Scholar 

  4. American Thoracic Society (1987) Standardisation of spirometry — 1987 update. Am Rev Respir Dis 136: 1285–1298

    Google Scholar 

  5. Hutchings MJ, Paull JD, Morgan DJ (1983) Determination of salbutamol in plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 277: 423–426

    Google Scholar 

  6. Nie NH, Hull CH, Jenkins JG, Steinbrumer K, Bent DH (1975) SPSS: Statistical package for the social sciences, 2nd edn. McGraw-Hill, New York

    Google Scholar 

  7. Brown RD, Manno JE (1987) ESTRIP, a basic computer programme for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691

    Google Scholar 

  8. Schuman S, Herxheimer H (1971) The bronchodilator action of salbutamol in asthmatics. Postgrad Med J 47 [Suppl]: 92–99

    Google Scholar 

  9. Rodenstein D, Stanescu DC (1982) Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest 76: 365–373

    Google Scholar 

  10. Ruffin RE, Montgomery JM, Newhouse MT (1978) Site of beta-adrenergic receptors in the respiratory tract: Use of fenoterol administered by two methods. Chest 74: 256–260

    Google Scholar 

  11. Martin AJ, Erben A, Landau LI, Phelan PD (1976) Assessment of buccal mucosa administration of salbutamol aerosol. In: Shaw DT (ed) Recent advances in aerosol science. John Wiley, London, pp 113–116

    Google Scholar 

  12. Collier JG, Dobbs RJ, William I (1980) Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol 9: 273–274

    Google Scholar 

  13. Kung M, Croley SW, Phillips BA (1987) Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 91: 382–387

    Google Scholar 

  14. Wade A (1980) Drug absorption. In: Pharmaceutical handbook. 19th edn. The Pharmaceutical Press, London, pp 307–308

    Google Scholar 

  15. Ohashi K, Turner P (1980) Buccal absorption characteristics of some selective and non-selective beta-adrenoceptor agonists and antagonists. Br J Clin Pharmacol 9: 120 p

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipworth, B.J., Clark, R.A., Dhillon, D.P. et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma. Eur J Clin Pharmacol 37, 567–571 (1989). https://doi.org/10.1007/BF00562546

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562546

Key words

Navigation